2019-10 University of Pittsburg study on new antibiotics for carbapenem-resistant Enterobacteriaceae
Acurx Successfully Completes Ph1 Clinical Trial for ACX-362E in CDI
https://www.prnewswire.com/news-releases/acurx-successfully-completes-ph1-clinical-trial-for-acx-362e-in-cdi-300908613.htmlAntibiotics Aren’t Profitable Enough for Big Pharma to Make More
https://www.bloomberg.com/news/articles/2019-05-03/antibiotics-aren-t-profitable-enough-for-big-pharma-to-make-moreAs Threat of Antibiotic Resistance Mounts, Biotechs Are Running Out of Cash and Time
https://morningconsult.com/2019/09/05/as-threat-of-antibiotic-resistance-mounts-biotechs-are-running-out-of-cash-and-time/Basilea announces positive results of phase 3 TARGET study with antibiotic ceftobiprole in the treatment of acute bacterial skin and skin structure infections (ABSSSI) | Small Molecules | News Channels
https://pipelinereview.com/index.php/2019080671964/Small-Molecules/Basilea-announces-positive-results-of-phase-3-TARGET-study-with-antibiotic-ceftobiprole-in-the-treatment-of-acute-bacterial-skin-and-skin-structure-infections-ABSSSI.htmlBiopharm firm tackling antibiotic resistance closes funding round - The Scotsman
https://www.scotsman.com/business/biopharm-firm-tackling-antibiotic-resistance-closes-funding-round-1-4994521Bitter pill: the truth about antibiotics | York Press
https://www.yorkpress.co.uk/news/17685126.bitter-pill-the-truth-about-antibiotics/Business of Health Care - New Antibiotics | KWBU
https://www.kwbu.org/post/business-health-care-new-antibioticsDebiopharm Awarded $2.1 Million From CARB-X in the Fight Against a Highly Resistant Nosocomial-Pneumonia Causing Superbug
https://finance.yahoo.com/news/debiopharm-awarded-2-1-million-123500032.htmlDoctor’s day: Big bugs, big drugs, big bucks!
https://timesofindia.indiatimes.com/blogs/Masquerader/doctors-day-big-bugs-big-drugs-big-bucks/EFPIA responds to EC President-elect prioritization of antimicrobial r
https://www.thepharmaletter.com/article/efpia-responds-to-ec-president-elect-prioritization-of-antimicrobial-resistanceEntasis Therapeutics Announces New Results Supporting Advancement of Multiple Pathogen-Targeted Antimicrobial Programs at ASM Microbe 2019 | BioSpace
https://www.biospace.com/article/entasis-therapeutics-announces-new-results-supporting-advancement-of-multiple-pathogen-targeted-antimicrobial-programs-at-asm-microbe-2019-/Fighting antimicrobial resistance requires new diagnostic tools - STAT
https://www.statnews.com/2019/10/24/antimicrobial-resistance-fight-requires-new-diagnostic-tools/Firms to work together on superbugs in China
https://www.thepharmaletter.com/article/firms-to-work-together-on-superbugs-in-chinaFluoroquinolone Antibiotics Pose a Huge Health Risk. Why Are Doctors Still Prescribing Them?
https://www.thedailybeast.com/fluoroquinolone-antibiotics-pose-a-huge-health-risk-why-are-doctors-still-prescribing-themFranco-German collaboration on novel antibiotics
https://www.thepharmaletter.com/article/franco-german-collaboration-on-novel-antibioticsHarrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics
https://finance.yahoo.com/news/harrow-health-forms-stowe-pharmaceuticals-113000361.htmlHow can economics tackle the issue of antimicrobial resistance?
https://www.openaccessgovernment.org/issue-of-antimicrobial-resistance/64575/IDSA board member urges Congressional effort to stabilize antibiotic market, encourage new drugs - Homeland Preparedness News
https://homelandprepnews.com/stories/34659-idsa-board-member-urges-congressional-effort-to-stabilize-antibiotic-market-encourage-new-drugs/New Antimicrobials One of the Potential Solutions to Resistant Superbugs - WHO
https://finance.yahoo.com/news/antimicrobials-one-potential-solutions-resistant-121700233.htmlNew FDA-Cleared Microbicidal Liquid Kills Deadly, Drug-Resistant Candida Auris Superbug on Contact
https://finance.yahoo.com/news/fda-cleared-microbicidal-liquid-kills-173500937.htmlNew Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant Pathogens | BioSpace
https://www.biospace.com/article/releases/new-studies-highlight-activity-of-xerava-against-gram-negative-and-gram-positive-clinical-isolates-including-multidrug-resistant-pathogens/New Studies Highlight Activity of XERAVA™ Against Gram-Negative and Gram-Positive Clinical Isolates, Including Multidrug-Resistant Pathogens | Business Wire
https://www.businesswire.com/news/home/20190624005075/en/New antibiotics aren't being made. That could cause 10 million deaths by 2050. — Economy
https://www.ecnmy.org/engage/new-antibiotics-arent-made-cause-10-million-deaths-2050/New class of antibiotics apparently also works against multi-resistant germs - Innovation Origins
https://innovationorigins.com/new-class-of-antibiotics-apparently-also-works-against-multi-resistant-germs/Next-gen antibiotic research funded | Mirage News
https://www.miragenews.com/next-gen-antibiotic-research-funded/Nosopharm and Evotec enter into collaboration to accelerate development of novel antibiotics | BioSpace
https://www.biospace.com/article/nosopharm-and-evotec-enter-into-collaboration-to-accelerate-development-of-novel-antibiotics/Novel Probiotic Strain Dramatically Reduces Antibiotic Resistance In Infants
https://finance.yahoo.com/news/novel-probiotic-strain-dramatically-reduces-100000276.htmlNovo Holdings REPAIR Impact Fund Invests USD 10 Million in Curza and Spero
https://finance.yahoo.com/news/novo-holdings-repair-impact-fund-140000122.htmlNovo Holdings invests over $10m in companies developing new antibiotics - EPM Magazine
https://www.epmmagazine.com/news/novo-holdings-invests-over-10m-in/Oxford Drug Design receives over £8m in grant and equity investment | Cambridge Network
https://www.cambridgenetwork.co.uk/news/oxford-drug-design-receives-over-%C2%A38m-grant-and-equity-investmentOxford Drug Design wins UK-China antimicrobial resistance grant - Pharmafield
https://pharmafield.co.uk/pharma_news/oxford-drug-design-wins-uk-china-antimicrobial-resistance-grant/Panel: Onus to Stop Abx Overuse Is on Prescribers | Medpage Today
https://www.medpagetoday.com/infectiousdisease/publichealth/82703Prokaryotics Receives $2.3 Million SBIR Award Supporting Its Immune Potentiation Program and Advances Two Additional SBIR-funded Antibiotic Programs into Phase 2 Lead Optimization
https://finance.yahoo.com/news/prokaryotics-receives-2-3-million-123000102.htmlQpex Biopharma to Provide First Public Presentations of Preclinical Data on the Novel Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 for IV and Oral Products at 2019 ASM Microbe Meeting
https://finance.yahoo.com/news/qpex-biopharma-first-public-presentations-120000183.htmlRedHill And Talicia In H. Pylori: The PDUFA Countdown - RedHill Biopharma Ltd. (NASDAQ:RDHL) | Seeking Alpha
https://seekingalpha.com/article/4282928-redhill-talicia-h-pylori-pdufa-countdownReducing Use Is Not The Answer: Here Are 5 Ways To Tackle Antibiotic Resistance
https://www.science20.com/news_staff/reducing_use_is_not_the_answer_here_are_5_ways_to_tackle_antibiotic_resistance-238041Shionogi to Present Cefiderocol and COT-143 Data at American Society for Microbiology Microbe 2019 Meeting
https://finance.yahoo.com/news/shionogi-present-cefiderocol-cot-143-143500692.htmlStewardship / Resistance Scan for Jul 17, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/07/stewardship-resistance-scan-jul-17-2019Study finds sizable delay in use of new antibiotics | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/07/study-finds-sizable-delay-use-new-antibioticsTechulon awarded funding to develop antimicrobial to kill drug-resistant bacteria - Homeland Preparedness News
https://homelandprepnews.com/stories/39542-techulon-awarded-funding-to-develop-antimicrobial-to-kill-drug-resistant-bacteria/The Radical Plan to Change How Antibiotics Get Developed | WIRED
https://www.wired.com/story/the-radical-plan-to-change-how-antibiotics-get-developed/UK biotech receives over £8m to advance drug resistant antibiotics - EPM Magazine
https://www.epmmagazine.com/news/uk-biotech-receives-over-8m-to-advance-drug-resistant-antib/Unless you act now, antibiotic resistance could kill 10million people by 2050 | Metro News
https://metro.co.uk/2019/05/15/unless-you-act-now-antibiotic-resistance-could-kill-10million-people-by-2050-9493186/X-Biotix Therapeutics Joins Antimicrobials Working Group
https://finance.yahoo.com/news/x-biotix-therapeutics-joins-antimicrobials-131300987.html